Report Description Table Of Content Research Methodology Download Free Sample

Market Snapshot

CAGR:8.67

2023

2032

Source: Market Expertz

Study Period	2019-2032
Base Year	2023
Forcast Year	2023-2032
CAGR	8.67

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Report Overview

The Atherectomy Market is poised to experience substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 5.62% between 2022 and 2032. The market size is anticipated to expand by USD 745.30 million over this period. The market's growth is driven by various factors, including the increasing prevalence of cardiovascular diseases, advancements in medical technology, and the demand for minimally invasive procedures for treating arterial blockages.

Atherectomy Market Overview:

Drivers:

The rising prevalence of cardiovascular diseases, including atherosclerosis and peripheral artery disease, is a major driver for the Atherectomy Market. These conditions result in the narrowing and blockage of arteries, leading to reduced blood flow. Atherectomy procedures involve the removal of plaque buildup from arterial walls, restoring blood flow and reducing the risk of heart attacks, strokes, and other complications.

Advancements in medical technology, particularly in atherectomy devices, contribute to the market's growth. Innovations such as laser atherectomy, rotational atherectomy, and directional atherectomy offer physicians improved precision and efficiency during procedures, enhancing patient outcomes.

Trends:

The Atherectomy Market is witnessing a trend toward minimally invasive treatments. Minimally invasive atherectomy procedures offer benefits such as reduced patient trauma, shorter hospital stays, faster recovery times, and lower healthcare costs. Patients and healthcare providers are increasingly opting for these procedures, driving the adoption of minimally invasive atherectomy devices.

Moreover, the integration of imaging technologies into atherectomy devices is gaining traction. Real-time imaging enables physicians to visualize the arterial blockage and monitor the progress of the atherectomy procedure, enhancing accuracy and efficacy.

Restraints:

One of the key challenges in the Atherectomy Market is the limited reimbursement coverage for atherectomy procedures. In certain regions, reimbursement policies may not adequately cover the costs of atherectomy devices and procedures, which can impact the adoption of these treatments.

Additionally, atherectomy procedures may pose risks such as vessel perforation, embolization, or damage to the arterial wall. These potential complications require careful patient selection, physician expertise, and comprehensive training to mitigate risks and ensure successful outcomes.

Atherectomy Market Segmentation by Application:

The Peripheral Artery Disease (PAD) segment is expected to witness significant growth in the Atherectomy Market. Peripheral artery disease affects the arteries outside of the heart and brain, commonly in the legs. Atherectomy procedures targeting peripheral arteries help alleviate symptoms such as pain, cramping, and impaired mobility.

Atherectomy Market Segmentation by Type:

Rotational atherectomy devices are projected to experience substantial growth in the Atherectomy Market. Rotational atherectomy involves the use of a rotating burr to remove plaque buildup from arterial walls. This method provides physicians with precise control and is effective for treating calcified lesions.

Regional Overview:

Download the report summary now!
Request pdf Sample

North America is anticipated to play a significant role in the global Atherectomy Market. The region's high prevalence of cardiovascular diseases, coupled with advanced healthcare infrastructure and adoption of innovative medical technologies, contributes to market growth.

Atherectomy Market Customer Landscape:

The Atherectomy Market serves various stakeholders, including healthcare providers, hospitals, outpatient clinics, and patients. Physicians specializing in interventional cardiology, vascular surgery, and radiology are key customers who perform atherectomy procedures.

Major Atherectomy Market Companies:

Key players in the Atherectomy Market are focused on research and development to enhance their product offerings and expand their market presence. Some prominent market players include:

Medtronic plc
Boston Scientific Corporation
Royal Philips N.V.
Cardiovascular Systems Inc.
Spectranetics Corporation
Terumo Corporation
B. Braun Melsungen AG
Straub Medical AG
Avinger Inc.
RA Medical Systems Inc.

Segment Overview:

The Atherectomy market report provides revenue forecasts at global, regional, and country levels, presenting insights into market trends and growth opportunities from 2019 to 2032. The report covers various segments, including:

Application Outlook (USD Million, 2019 - 2032)
- Coronary Artery Disease (CAD)
- Peripheral Artery Disease (PAD)
Type Outlook (USD Million, 2019 - 2032)
- Directional Atherectomy Devices
- Laser Atherectomy Devices
- Rotational Atherectomy Devices
- Orbital Atherectomy Devices
Geography Outlook (USD Million, 2019 - 2032)
- North America
  - The United States
  - Canada
- Europe
  - Germany
  - France
  - United Kingdom
  - Rest of Europe
- APAC
  - China
  - Japan
  - India
- South America
  - Brazil
  - Argentina
  - Rest of South America
- Middle East & Africa
  - Saudi Arabia
  - UAE
  - South Africa
  - Rest of the Middle East & Africa

TABLE OF CONTENTS: GLOBAL ATHERECTOMY MARKET

Chapter 1. MARKET SYNOPSIS

1.1. Market Definition

1.2. Research Scope & Premise

1.3. Methodology

1.4. Market Estimation Technique

Chapter 2. EXECUTIVE SUMMARY

2.1. Summary Snapshot, 2016 – 2027

Chapter 3. INDICATIVE METRICS

3.1. Macro Indicators

Chapter 4. ATHERECTOMY MARKET SEGMENTATION & IMPACT ANALYSIS

4.1. Atherectomy Segmentation Analysis

4.2. Industrial Outlook

4.3. Price Trend Analysis

4.4. Regulatory Framework

4.5. Porter’s Five Forces Analysis

4.5.1. Power Of Suppliers

4.5.2. Power Of Buyers

4.5.3. Threat Of Substitutes

4.5.4. Threat Of New Entrants

4.5.5. Competitive Rivalry

Chapter 5. ATHERECTOMY MARKET BY Type INSIGHTS & TRENDS

5.1. Segment 1 Dynamics & Market Share, 2019 & 2027

5.2. Squamous Cell Carcinoma

5.2.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

5.2.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

5.3. Large Cell Carcinoma

5.3.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

5.3.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

5.4. Adenocarcinoma

5.4.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

5.4.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

Chapter 6. ATHERECTOMY MARKET BY End use INSIGHTS & TRENDS

6.1. Segment 2 Dynamics & Market Share, 2019 & 2027

6.2. Hospitals

6.2.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

6.2.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

6.3. Ambulatory Surgical Centers

6.3.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

6.3.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

6.4. Medical Research Institutes

6.4.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

6.4.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

6.5. Cardiac Catherization Lab

6.5.1. Market Estimates And Forecast, 2016 – 2027 (USD Million)

6.5.2. Market Estimates And Forecast, By Region, 2016 – 2027 (USD Million)

Chapter 7. ATHERECTOMY MARKET REGIONAL OUTLOOK

7.1. Atherectomy Market Share By Region, 2019 & 2027

7.2. NORTH AMERICA

7.2.1. North America Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.2.2. North America Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.2.3. North America Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.2.4. North America Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.2.5. U.S.

7.2.5.1. U.S. Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.2.5.2. U.S. Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.2.5.3. U.S. Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.2.5.4. U.S. Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.2.6. CANADA

7.2.6.1. Canada Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.2.6.2. Canada Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.2.6.3. Canada Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.2.6.4. Canada Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3. EUROPE

7.3.1. Europe Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.3.2. Europe Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.3.3. Europe Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.3.4. Europe Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3.5. GERMANY

7.3.5.1. Germany Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.3.5.2. Germany Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.3.5.3. Germany Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.3.5.4. Germany Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3.6. FRANCE

7.3.6.1. France Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.3.6.2. France Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.3.6.3. France Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.3.6.4. France Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.3.7. U.K.

7.3.7.1. U.K. Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.3.7.2. U.K. Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.3.7.3. U.K. Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.3.7.4. U.K. Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4. ASIA-PACIFIC

7.4.1. Asia Pacific Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.4.2. Asia Pacific Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.4.3. Asia Pacific Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.4.4. Asia Pacific Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.5. CHINA

7.4.5.1. China Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.4.5.2. China Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.4.5.3. China Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.4.5.4. China Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.6. INDIA

7.4.6.1. India Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.4.6.2. India Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.4.6.3. India Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.4.6.4. India Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.7. JAPAN

7.4.7.1. Japan Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.4.7.2. Japan Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.4.7.3. Japan Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.4.7.4. Japan Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.4.8. AUSTRALIA

7.4.8.1. Australia Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.4.8.2. Australia Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.4.8.3. Australia Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.4.8.4. Australia Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.5. MIDDLE EAST AND AFRICA (MEA)

7.5.1. Mea Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.5.2. Mea Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.5.3. Mea Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.5.4. Mea Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

7.6. LATIN AMERICA

7.6.1. Latin America Atherectomy Market Estimates And Forecast, 2016 – 2027, (USD Million)

7.6.2. Latin America Atherectomy Market Estimates And Forecast By Segment 1, 2016 –2027, (USD Million)

7.6.3. Latin America Atherectomy Market Estimates And Forecast By Segment 2, 2016 –2027, (USD Million)

7.6.4. Latin America Atherectomy Market Estimates And Forecast By Production Process, 2016 –2027, (USD Million)

7.6.5. Latin America Atherectomy Market Estimates And Forecast By Segment 3, 2016 –2027, (USD Million)

Chapter 8. COMPETITIVE LANDSCAPE

8.1. Market Share By Manufacturers

8.2. Strategic Benchmarking

8.2.1. New Product Launches

8.2.2. Investment & Expansion

8.2.3. Acquisitions

8.2.4. Partnerships, Agreement, Mergers, Joint-Ventures

8.3. Vendor Landscape

8.3.1. North American Suppliers

8.3.2. European Suppliers

8.3.3. Asia-Pacific Suppliers

8.3.4. Rest Of The World Suppliers

Chapter 9. COMPANY PROFILES

9.1. Phillips Healthcare

9.1.1. Company Overview

9.1.2. Financial Performance

9.1.3. Product Insights

9.1.4. Strategic Initiatives

9.2. Bayer AG

9.2.1. Company Overview

9.2.2. Financial Performance

9.2.3. Product Insights

9.2.4. Strategic Initiatives

9.3. BARD Peripheral Vascular Inc

9.3.1. Company Overview

9.3.2. Financial Performance

9.3.3. Product Insights

9.3.4. Strategic Initiatives

9.4. Boston Scientific

9.4.1. Company Overview

9.4.2. Financial Performance

9.4.3. Product Insights

9.4.4. Strategic Initiatives

9.5. Medtronics

9.5.1. Company Overview

9.5.2. Financial Performance

9.5.3. Product Insights

9.5.4. Strategic Initiatives

9.6. Cardiovascular Systems Inc

9.6.1. Company Overview

9.6.2. Financial Performance

9.6.3. Product Insights

9.6.4. Strategic Initiatives

9.7. Avinger Inc

9.7.1. Company Overview

9.7.2. Financial Performance

9.7.3. Product Insights

9.7.4. Strategic Initiatives

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

Our expert analysts collaborate directly with you to comprehend your specific needs.
Get data on regions, segments, competitors, and vendors of your choice.
Information is presented in alignment with your exact preferences and formatting.

Request for customization

Ask For Discount

Free Sample Report

"Find new revenue generation opportunities"

Atherectomy Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032